NCT02693938 is a NA clinical trial of Follicular Euglycemic clamp in Type 1 Diabetes, sponsored by Yale University.

Who is sponsoring NCT02693938?

NCT02693938 is sponsored by Yale University.

What drugs are being tested in NCT02693938?

Interventions in NCT02693938: Follicular Euglycemic clamp, Luteal Euglycemic clamp.

What condition does NCT02693938 study?

NCT02693938 studies Type 1 Diabetes.

Is NCT02693938 still recruiting?

NCT02693938 is currently completed. Last updated 28 February 2022.

Last reviewed 2022-02-28 · How we verify

NCT02693938

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Blood Glucose Variability and Insulin Action During Menstrual Cycle in Females With Type 1 Diabetes

Completed NA Last updated 28 February 2022

What this trial tests

NA trial testing Follicular Euglycemic clamp in Type 1 Diabetes in 28 participants. Completed in 7 February 2020.

Timeline

13 November 2019

Primary endpoint
7 February 2020

7 February 2020

Quick facts

Lead sponsor	Yale University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	28
Start date	13 November 2019
Primary completion	7 February 2020
Estimated completion	7 February 2020
Sites	1 location across United States

Drugs / interventions tested

Follicular Euglycemic clamp
Luteal Euglycemic clamp

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →

Sponsor

Yale University

Who can join

Adults 12 to 35, female only, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is designed to look at differences in responsiveness to the subcutaneous injection of a standardized dose of rapid-acting insulin analog and blood glucose variability during different phases of the menstrual cycle in females with type 1 diabetes (T1D).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Insulin Replacement Across the Menstrual Cycle in Women with Type 1 Diabetes: An In Silico Assessment of the Need for Ad Hoc Technology.
Diaz C JL, Fabris C, Breton MD, Cengiz E. · · 2022 · cited 10× · PMID 35714349 · DOI 10.1089/dia.2022.0154

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Yale University trials

Trials by the same sponsor.

NCT06900998 — Pilot Study: Effects of Nimodipine on Alcohol Drinking · Phase 2 · not yet recruiting
NCT04910984 — Developing a Chatbot to Promote HIV Testing · NA · not yet recruiting
NCT07458087 — Accuracy of the Accuro 3S · NA · not yet recruiting
NCT07398404 — A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Pa · Phase 1, PHASE2 · not yet recruiting
NCT07305324 — Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02693938 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yale University
Last refreshed: 28 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02693938.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing